BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
Stock Advice on Ranbaxy Laboratories
Dr Reddy's Lab top pick in pharma: IIFL Capital
2.23 pm | 22 May 2013 | Source: CNBC-TV18
Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...
Switch to Cipla from Ranbaxy Labs: Joshi
7.17 pm | 21 May 2013 | Source: CNBC-TV18
Sharmila Joshi, Head of Equity, Peerless Securities is of the view that one can switch to Cipla from Ranbaxy Laboratories....
Short Ranbaxy Lab, Adani Enterprises: SP Tulsian
7.22 pm | 20 May 2013 | Source: CNBC-TV18
SP Tulsian of sptulsian.com is of the view that one can short Adani Enterprises with a target of Rs 239."Short Ranbaxy Laboratories with a target of R...
Hold Ranbaxy in portfolio, says Atul Badkar
10.41 am | 15 May 2013 | Source: CNBC-TV18
One should hold Ranbaxy Laboratories in the portfolio and from current level it can go to Rs 475, says Atul Badkar, VP - Institutional Equities - Deri...
Check Out: Super Six stocks for May 15
9.14 am | 15 May 2013 | Source: CNBC-TV18
Rakesh Gandhi of FRR Shares is bullish on Ranbaxy Laboratories and recommended to buy around Rs 450 with a stop loss of Rs 430 and short-term target o...
Tough for Ranbaxy to revive US biz now: Antique
10.26 am | 14 May 2013 | Source: CNBC-TV18
Pharama analyst, Anmol Ganjoo beleives that acceptence of this felony charges will not only be sentiment negative for Ranbaxy but it will hit their b...
Quick Links for Ranbaxy Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.